These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5855557)

  • 1. Ultraviolet cystoscopy in patients with bladder cancer.
    Whitmore WF; Bush IM
    Trans Am Assoc Genitourin Surg; 1965; 57():149-55. PubMed ID: 5855557
    [No Abstract]   [Full Text] [Related]  

  • 2. [The importance of tetracycline fluorescence for the early diagnosis of malignant bladder neoplasms].
    Ziehen HP; Oswald K
    Z Urol Nephrol; 1970 Jul; 63(7):523-30. PubMed ID: 5476613
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis of bladder carcinoma].
    Hofmann W
    Z Urol Nephrol; 1974 Mar; 67(3):227-9. PubMed ID: 4603468
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultraviolet light cystoscopy in patients with bladder cancer. One year's experience.
    Sorensen BL; Barlebo H; Gammelgaard PA; Soeborg Ohlsen A
    Scand J Urol Nephrol; 1969; 3(3):193-200. PubMed ID: 5375748
    [No Abstract]   [Full Text] [Related]  

  • 5. Occult cancer of the bladder. Its detection by ultraviolet tetracycline cystoscopy.
    Bush IM; Whitmore WF
    J Med Soc N J; 1967 Feb; 64(2):56-60. PubMed ID: 5231700
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-morphologic parallels in tumors of the urinary bladder].
    Kliucharev BV
    Vopr Onkol; 1968; 14(12):22-7. PubMed ID: 5714180
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening cystoscopy and survival of spinal cord injured patients with squamous cell cancer of the bladder.
    Navon JD; Soliman H; Khonsari F; Ahlering T
    J Urol; 1997 Jun; 157(6):2109-11. PubMed ID: 9146592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Your patient with carcinoma of the urinary bladder. Options for organ preservation].
    Zaak D
    MMW Fortschr Med; 2003 Jan; 145(5):28-32. PubMed ID: 12619205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet cystoscopy.
    Whitmore WF; Bush IM
    JAMA; 1968 Mar; 203(12):1057-9. PubMed ID: 5694368
    [No Abstract]   [Full Text] [Related]  

  • 10. Current world literature. Bladder cancer.
    Curr Opin Urol; 2007 Sep; 17(5):378-80. PubMed ID: 17910129
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
    Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
    J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence cystoscopy for nonmuscle invasive bladder cancer: is the honeymoon over for the blue light special?
    Shah JB; Kamat AM
    Cancer; 2011 Mar; 117(5):882-3. PubMed ID: 20960505
    [No Abstract]   [Full Text] [Related]  

  • 13. FISH and genetics advance bladder-cancer diagnosis.
    Hollenberg G
    MLO Med Lab Obs; 2004 Jun; 36(6):26-7. PubMed ID: 15242179
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Principles of diagnosis of epithelial neoplasms of the urinary bladder ].
    Stapor K; Jeromin L
    Pol Przegl Chir; 1969; 41(5):706-11. PubMed ID: 5788336
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
    Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
    Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
    Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
    J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent diagnosis of urothelial carcinoma and squamous cell carcinoma of the bladder in a patient with a vesicorectal fistula from invasive rectal cancer.
    Kodama K; Mizuno T; Imahori T; Ida M; Matsubara F
    Int J Urol; 2006 Mar; 13(3):296-8. PubMed ID: 16643630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
    Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
    J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
    Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
    J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.